scispace - formally typeset
A

Ana Chauca-Diaz

Researcher at Anschutz Medical Campus

Publications -  5
Citations -  187

Ana Chauca-Diaz is an academic researcher from Anschutz Medical Campus. The author has contributed to research in topics: Cancer & Bladder cancer. The author has an hindex of 4, co-authored 5 publications receiving 90 citations. Previous affiliations of Ana Chauca-Diaz include University of Colorado Boulder.

Papers
More filters
Journal ArticleDOI

Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy.

TL;DR: It is shown across multiple murine tumor and metastasis models that CCR2 antagonism in combination with anti- PD-1 therapy leads to sensitization and enhanced tumor response over anti-PD-1 monotherapy and that enhanced treatment response correlates with enhanced CD8 + T cell recruitment and activation and a concomitant decrease in CD4 + regulatory T cell.
Journal ArticleDOI

Androgen Receptor Regulates CD44 Expression in Bladder Cancer.

TL;DR: The role of the androgen receptor (AR) in the development of both experimental and human bladder cancer is less clear, with literature indicating that more advanced stage and grade disease are associated with reduced AR expression.
Journal ArticleDOI

Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.

TL;DR: A novel and functionally important intracellular location of CD24 is defined; it is explained why surCD24- cells can remain aggressive, and the need to consider nucCD24 in both fundamental research and therapeutic development is highlighted.